Trial · NCT07890883
Bone Health in Adults With Duchenne Muscular Dystrophy: A Survey on Osteoporosis, Fractures and Treatment.
NCT07890883, Recruiting, Istituto Giannina Gaslini
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Bone Health in Adults With Duchenne Muscular Dystrophy: A Survey on Osteoporosis, Fractures and Treatment. Trials, record NCT07890883. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07890883
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Bone Health in Adults With Duchenne Muscular Dystrophy: A Survey on Osteoporosis, Fractures and Treatment.
- NCT number
- NCT07890883
- Status
- Recruiting
- Enrollment
- 200 participants, estimated
- Lead sponsor
- Istituto Giannina Gaslini
- Conditions
- Duchenne Muscular Dystrophy (DMD)
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Prevalence of Fragility Fractures in Adult Patients with DMD | Baseline | To determine the prevalence of extremity fractures in adult patients with Duchenne muscular dystrophy based on review of clinical records. |
| Secondary | Prevalence of Vertebral Fractures in Adult Patients with DMD | Baseline | To determine the prevalence of vertebral fractures in adult patients with Duchenne muscular dystrophy based on lateral thoracolumbar spine radiographs (T4-L4). |
| Secondary | Fracture Treatment Patterns | Baseline | To describe the treatments administered for fragility fractures in adult patients with Duchenne muscular dystrophy. |
| Secondary | Serum Biomarkers of Bone Metabolism and Bone-Muscle Crosstalk | Baseline | To measure serum analytes involved in bone metabolism and bone-muscle crosstalk in patients with DMD and compare their levels with those of healthy male controls. |
| Secondary | Genetic Modifiers Associated with Fracture Risk | Baseline | To identify genetic variants potentially associated with an increased risk of fractures in patients with DMD through DNA analysis and genome-wide association studies (GWAS). |
| Secondary | Bone Mineral Density of the Lumbar Spine (L1-L4) | Baseline | To assess bone mineral density at the lumbar spine (L1-L4) using dual-energy X-ray absorptiometry (DXA). |
| Secondary | Bone Mineral Density of Total Body Less Head (TBLH) | Baseline | To assess bone mineral density of total body less head (TBLH) using dual-energy X-ray absorptiometry (DXA). |
| Secondary | Peak Expiratory Flow (PEF) | Baseline | To assess respiratory function by measuring peak expiratory flow (PEF). |
| Secondary | Forced Vital Capacity (FVC) | Baseline | To assess respiratory function by measuring forced vital capacity (FVC). |
| Secondary | Respiratory Support Status | Baseline | To record respiratory support status at the study visit. |
1 to 10 of 17Source ClinicalTrials.gov
See all 17 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07890883
GET https://conductscience.org/api/trials/v1/NCT07890883/registered